Abstract
Z-DNA is known to be a left-handed alternative form of DNA and has important biological roles as well as being related to cancer and other genetic diseases. It is therefore important to investigate Z-DNA structure and related biological events in living cells. However, the development of molecular probes for the observation of Z-DNA structures inside living cells has not yet been realized. Here, we have succeeded in developing site-specific trifluoromethyl oligonucleotide DNA by incorporation of 8-trifluoromethyl-2′-deoxyguanosine (FG). 2D NMR strongly suggested that FG adopted a syn conformation. Trifluoromethyl oligonucleotides dramatically stabilized Z-DNA, even under physiological salt concentrations. Furthermore, the trifluoromethyl DNA can be used to directly observe Z-form DNA structure and interaction of DNA with proteins in vitro, as well as in living human cells by19F NMR spectroscopy for the first time. These results provide valuable information to allow understanding of the structure and function of Z-DNA.
INTRODUCTION
Z-DNA plays a critical role in gene expression (1), recombination (2,3), regulation (4,5). Previous evidence suggests that Z-DNA sequences are required for chromatin-dependent activation of the CSF1 promoter (6). A recent study showed that the Z-DNA binding domain of the vaccinia virus is necessary to inhibit IFN-primed virus-induced necroptosis (7). The amount of data that suggests the key role of Z-DNA in gene regulation continues to increase. Several proteins have been reported to specifically bind with Z-form DNA, such as ADAR1, DLM1, PKZ and E3L, and further regulate transcription or gene inhibition (8–20). Recent studies also suggested the relationship of Z-form structure and several diseases, such as cancer and inflammation (21–23). We recently suggested that influenza virus Z-form nucleic-acids induce ZBP1-mediated necroptosis (24). Therefore, the biological importance of Z-DNA lets it become attractive structures as a therapeutic target.
The investigation of the Z-DNA conformations associated with biological events is essential to understand the functions of Z-DNA. Despite the biological importance of the structure of Z-DNA, its chemical properties are not well understood, presumably because of the difficulty in obtaining stable Z-form oligonucleotides under physiological salt conditions (25–28), and the development of molecular probes for the observation of the structure of Z-DNA inside living cells has not yet been realized. To achieve this goal, there are two main challenges that need to be addressed: first, stabilizing the Z-DNA conformation under a physiological salt condition; secondly, a useful approach to investigate the Z-DNA structure in living cells.
In this study, we undertook the challenge of performing trifluoromethylation of 2′-deoxyguanosine-containing oligonucleotides and applying them to investigate Z-DNA structure and function. We succeeded in the one-step incorporation of a trifluoromethyl (CF3) group in the 8-position of 2′-deoxyguanosine and the site-specific incorporation of 8-trifluoromethyl-2′-deoxyguanosine (FG) into oligomer DNA sequences. The incorporation of CF3 would improve physicochemical properties and/or modulate the conformation of 2′-deoxyguanosine from anti to syn (29–32) and further dramatically stabilize the Z-DNA conformation at a physiological salt condition. Furthermore, after incorporation into biomolecules, the CF3 group can be used as a potential 19F NMR reporter tag for studying structures and properties of target molecules (33–42). 19F is an ideal conformational probe owing to its high sensitivity and low background signal in biological samples (35–42). We have recently shown that the 19F sensor can be used to study the G-quadruplex structure in living cells (38–40). The trifluoromethyl DNA can be used to directly study Z-form DNA structure and interaction of DNA with protein in vitro, as well as investigating the Z-DNA structure in living human cells by 19F NMR spectroscopy. Therefore, our developed trifluoromethyl oligonucleotide DNA perfectly addressed the two challenges above. These results provide valuable information to allow understanding of the structure and function of Z-DNA in vitro and in living cells.
MATERIALS AND METHODS
8-trifluoromethyl-2′-deoxyguanosine
1.3 g (5.0 mmol) of 2′-deoxyguanosine was weighed and placed in a two-neck flask under argon. The following materials were added to the flask: 240 ml of dimethyl sulfoxide (DMSO), 7.5 ml of a 1 N sulfuric acid in DMSO, 5.0 ml of a 4.3 M DMSO solution of trifluoromethyl iodide (21.50 mmol), 0.17 ml of 30% hydrogen peroxide aqueous solution and 2.3 ml of a 1.0 M aqueous solution of iron (II) sulfate. The mixture was stirred for 15 min at room temperature. NaHCO3 aqueous solution was added to neutralize the mixture. The supernatant was obtained by centrifugation and extracted with 200 ml ethyl acetate. The water layer was evaporated and purification by silica gel column chromatography. 750 mg white solid product was obtained (yield: 45%). 1H NMR (400 MHz, DMSO-d6) δ 10.86 (s, 1H), 6.73 (m, 2H), 6.16 (t, J = 7.1 Hz, 1H), 5.29 (d, J = 4.3 Hz, 1H), 4.87 (t, J = 5.9 Hz, 1H), 4.43 (br s, 1H), 3.86 (m, 1H), 3.64 (m, 1H), 3.54 (m, 1H), 3.13 (m, 1H), 2.16 (q, J = 3.9 Hz,1H). 13C-NMR (100 MHz, DMSO-d6) δ 156.47, 154.29, 152,43, 132.77, 118.64, 116.46, 88.34, 84.67, 70.98, 61.92, 37.32. 19F NMR (372 MHz, DMSO-d6) δ 60.00. HRMS (ESI) for C11H11O4N5F3 [M−H]−: Calcd. 334.0758; Found. 334.0767.
N 2-Dimethylformamidyl-8-trifluoromethyl-2′-deoxyguanosine (1)
FG (250 mg, 0.75 mmol) was co-evaporated with anhydrous DMF (5 ml) three times, followed by suspension in 4 ml of anhydrous DMF, and N,N-dimethylformamide diethyl acetal (0.9 ml, 5.3 mmol) was added. The mixture was stirred for at room temperature 1 h under argon. Then the solvent was evaporated and the residues were purified by medium pressure liquid chromatography (MPLC). Pale-yellow crystal of 1 (210 mg, 72%) was obtained. 1H NMR (400 MHz, DMSO-d6) δ 11.75 (s, 1H), 8.56 (s, 1H), 6.21 (t, J = 6.8 Hz, 1H), 5.38 (d, J = 6.8 Hz, 1H), 4.86 (t, J = 6.8 Hz, 1H), 4.50 (br s, 1H), 3.87 (m, 1H), 3.67 (m, 1H), 3.56 (m, 1H), 3.19 (s, 3H), 3.12 (m, 1H), 3.08 (s, 3H), 2.20 (m, 1H). HRMS (ESI) for C14H16O6N4F3 [M−H]−: Calcd. 389.1180; Found. 389.1186.
5′-O-Dimethoxytrityl-N2-dimethylformamidyl-8-trifluoromethyl-2′-deoxyguanosine (2)
Compound 2 (210 mg, 0.54 mmol) was dried three times with 5 ml of anhydrous pyridine and dissolved in anhydrous pyridine (6.5 ml). N,N-Diisopropylethylamine (0.36 ml, 2.16 mmol) and 4,4′-dimethoxytritylchloride (356 mg, 1.05 mmol) were added. The mixture was stirred at room temperature for 5 h under argon. Then 20 ml of CH2Cl2 and 20 ml of 5% NaHCO3 aqueous solution were added to stop the reaction. The water layer was extracted three times with CH2Cl2. The organic layer was dried over Na2SO4 and concentrated in vacuo. The residue was purified by MPLC to give compound 2 (295 mg, 79%) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.66 (s, 1H), 8.36 (s, 1H), 7.70–7.66 (m, 1H), 7.38–7.35 (m, 2H), 7.30–7.19 (m, 6H), 6.78–6.76 (m, 4H), 6.34 (t, J = 2.3 Hz, 1H), 4.79 (m, 1H), 3.95 (q, J = 5.8 Hz, 1H), 3.56 (s, 6H), 3.54 (t, J = 4.9 Hz, 1H), 3.31 (t, J = 3.6 Hz, 1H), 3.18 (q, J = 5.7 Hz, 1H), 3.07 (s, 3H), 2.95 (s, 3H), 2.38 (q, J = 5.5 Hz, 1H), 2.15 (d, J = 2.5 Hz, 1H). HRMS (ESI) for C35H34O6N6F3 [M−H]−: Calcd. 691.2486; Found. 691.2495.
3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-dimethoxytrityl-N2 dimethylformamidyl-8-trifluoromethyl-2′-deoxyguanosine (3)
Compound 3 (310 mg, 0.45 mmol) was dried three times by co-evaporation of 5 ml of anhydrous acetonitrile and dissolved in 5 ml of CH2Cl2. Then it was treated with dry N,N-diisopropylethylamine (291 μl, 1.8 mmol) and 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (390 μl, 1.8 mmol). The mixture was stirred at room temperature for 30 min under argon. After addition of 20 ml of CH2Cl2, the reaction was stopped by adding 20 ml of 5% NaHCO3 aqueous solution. The aqueous layer was extracted three times with CH2Cl2. The combined organic layers were dried over Na2SO4 and the solvent was evaporated in vacuo. The residue was purified by recycling HPLC to give compound 4 (320 mg, 80%) as a white solid. 1H NMR (400 MHz, CDCl3), 8.60 (s, 2H), 8.37 (s, 1H), 8.32 (s, 1H), 7.48 (m, 2H), 7.38–7.16 (m, 20H), 6.75–6.70 (m, 6H), 6.34–6.30 (m, 2H), 5.01 (q, J = 2.4 Hz, 1H), 4.87 (q, J = 3.7 Hz, 1H), 3.81–3.73 (m, 14H), 3.62–3.50 (m, 4H), 3.39–3.21 (m, 8H), 3.03 (s, 6H), 2.93 (m, 6H), 2.59–2.25 (m, 6H), 1.25–1.06 (m, 24H). 19F NMR (372 MHz, CDCl3) δ 60.88, 60.91. 31P NMR (161 MHz, CDCl3) δ 149.23, 148.97. HRMS (ESI) for C44H51O7N8F3P [M–H]−: Calcd. 891.3565; Found. 891.3578.
DNA sample preparation
By using an automatic solid-phase phosphoramidite chemistry and DNA synthesizer, FG was incorporated into the designed DNA sequence at a ratio of 1.0 μmol. After DNA synthesis, the FG labelled DNA was cleavage from the column and deprotected by using AMA (Ammonium Hydroxide/40% aqueous methylamine 1:1 v/v) at room temperature for 20 min and at 338 K for 10 min, respectively. The oligomers were further purified by HPLC in a linear gradient of 50 mM ammonium formate in 1:1 acetonitrile/H2O and 50 mM ammonium formate in H2O. The oligomers were desalted through a NAP 10 column (GE Healthcare) and identified by MALDI-TOF-MS on an Autoflex III smart beam mass spectrometer (negative mode). For 6-mer 5′-CGCFGCG-3′ sequence, cal: 1858.33, found: 1859.21; for 8-mer CFGCACFGCG sequence, cal: 2529.42, found: 2528.58.
Zα protein preparation
The human ADAR1 plasmid was used as a template for polymerase chain reaction. The Zα domain (122–199) cDNAs of human ADAR1 protein was cloned into the pGEX-6p-1 vector (GE Healthcare, Chicago, IL, USA) between the EcoRI and XhoI sites using the following sets of primers to express an N-terminal glutathione S-transferase (GST) fusion protein: forward d(GCG GAT CCG GTG TTG ATT GCC TTT CCT CAC ATT), and reverse d(CGC TCG AGC TAG ACC GCG ATT TTC CAC AAA GGG GGT GTT). The construct was verified by automated DNA sequencing. DNA oligomers were obtained from Operon Biotechnologies (Japan). The Escherichia coli strain BL21 (DE3) pLysS-competent cells were transformed with the vector, and transformants were grown at 310 K in Luria Bertani medium containing ampicillin (0.1 mg/ml). Protein expression was induced at A600 = 0.6 with 0.1 mM isopropyl β-d-1-thiogalactopyranoside. Cells were harvested after 3 h and centrifuged at 6400 g for 20 min. The E. coli pellets were resuspended in 20 mM Tris–HCl (pH 8.0) containing 150 mM NaCl. The supernatants containing the expressed proteins were lysed by sonication (model UR-20P, Tomy Seiko, Japan) and centrifuged at 16 200 g for 15 min at 277 K. The supernatant and glutathione agarose (MilliporeSigma, Burlington, MA, USA) were incubated with gentle mixing for 1 h at 277 K; the resin was washed with 20 mM Tris–HCl (pH 8.0) containing 150 mM NaCl and 1% (v/v) Triton X-100) at 277 K. GST-tags were cleaved using a buffer containing 8 units/ml PreScission protease (GE Healthcare) on a resin for 16 h at 277 K, and the protein was eluted with 20 mM Tris–HCl (pH 8.0) containing 20 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol. Purification of protein was performed as described previously (43). The protein concentrations were determined using a BCA Protein Assay Kit (Thermo Scientific, Altham, MA, USA). The Zα protein was stocked with a final concentration in 350 μM with 20 mM Na-PO4 buffer (pH 7.0) and 1 mM DTT.
CD measurement
CD experiments were performed by using a Jasco model J-820 CD spectrophotometer. For the salt concentration experiments, the Z-DNA sample was prepared at a 25 μM duplex concentration in the presence of 1 mM Na-PO4 buffer (pH 7.0) and various concentrations of sodium chloride. For DNA–protein binding experiment, the Z-DNA sample was prepared at the designed duplex concentration in the presence of 1 mM Na-PO4 buffer (pH 7.0) and different ratios of Zα protein.
Introduction of trifluoromethyl DNA into HeLa cells by SLO treatment
The detailed procedure could refer to our previous report (40). HeLa cells (2 × 107) grown in DMEM medium containing 10% FBS under a 5% CO2 atmosphere were collected and then washed twice with HBSS buffer. SLO (biologicalemia) was activated with 10 mM DTT and 0.05% BSA at 310 K for 2 h. To form pores in the plasma membrane, activated SLO was added to HeLa cells at a final concentration of 0.1 μg/ml, followed by gentle rotation incubation at 277 K for 15 min. After washing three times with ice-cold HBSS buffer, cells were incubated with 3 mM trifluoromethyl Z-DNA in 500 μl of HBSS buffer at 310 K for 30 min, and then shaken. Cells were resealed by adding ice-cold HBSS buffer (containing 1 mM CaCl2). After 30 min of incubation at 277 K, the cells were washed twice with HBSS buffer containing 1 mM CaCl2. The resealed cells were seeded in HBSS buffer containing 14% percoll (centrifuged at 2000 × g for about 1 h), and then centrifuged at 400 × g for 3 min. After centrifugation, the cell pellet (viable cells) was washed three times with HBSS buffer.
19F NMR measurement
Z-DNA samples were dissolved in 150 μl of a designed solution containing 1 mM Na-PO4 buffer (pH 7.0) and 10% D2O in various concentrations of NaCl. The 19F NMR spectrum was measured on a Bruker AVANCE 400 MHz spectrometer at a frequency of 376.05 MHz and referenced to the internal standard CF3COOH (–75.66 ppm). The experimental parameters are recorded as follows: spectral width 89.3 kHz, 19F excitation pulse 15.0 μs, relaxation delay 1.5 s, acquisition time 0.73 s, scan numbers 1024–4096, and line width 3. The 19F–1H HOESY experiment was performed on a Bruker AVANCE 400 MHz spectrometer using the hoesyfhqfqnrv pulse program at 296 K. Mixing time is 2 s. For DNA–protein binding experiment, the Z-DNA sample was prepared at 15 μM or 30 μM duplex concentration in the presence of 1 mM Na-PO4 buffer (pH 7.0) and different ratios of Zα protein. For in-cell 19F NMR measurement, the transfected cells were suspended in 200 μl of DMEM with 10% D2O and transferred to a Shigemi tube (Shigemi 5 mm Symmetrical NMR microtube). The experiment was performed at 296 K with a scan numbers value in 2048 or 4096. After the intracellular NMR measurement, 100 μl of DMEM was added to the cell suspension, and the supernatant was collected by centrifugation at 400 g for 3 min. The 19F NMR spectrum of the supernatant was measured with the same number of scans as the in-cell 19F NMR measurement.
Molecular modeling
We manually generated the model of DNA structure based on the reported structure using the BIOVIA Discovery Studio 4.5. The molecular dynamics simulation was performed by the standard dynamics cascade in BIOVIA Discovery Studio 4.5 with some modifications. The structure was heated from 50 K to 300 K over 4 ps and equilibration at 300 K with 100 ps simulation time. The save results interval in the production step was 2 ps during 100 ps simulation time at 300 K. 10 best conformations generated by simulation were further energy minimized. The conformation with lowest energy was selected as shown in Figure 4.
RESULTS AND DISCUSSION
Synthesis of trifluoromethyl Z-DNA
Using a catalytic system that consisted of H2O2, FeSO4 and H2SO4 in DMSO, we succeeded in the one-step synthesis of FG through a radical reaction between dG and CF3I, with a yield of 45% (Scheme 1 and Supplementary Figure S1–S12). FG is expected to adopt a syn conformation due to the space steric effect of the CF3 group at the 8-position of guanine. To verify our hypothesis, a 19F–1H heteronuclear Overhauser effect spectroscopy (HOESY) experiment was performed. The cross peak between the CF3 group at the C8 position and C1′H in the 2D NMR spectrum strongly suggested that FG adopted a syn conformation (Scheme 1). This result is consistent with our previous reports that methylation was favorable for the syn conformation of the guanines (29–32). We further performed the site-specific incorporation of FG into a series of DNA sequences by phosphoramidite chemistry (Figure 1).
CD characterization of trifluoromethyl Z-DNA sequences
Circular dichroism (CD) spectroscopy can be used to discriminate the B- and Z-DNA conformations (29–32,43). In Z-DNA, a negative Cotton effect appears at 295 nm, whereas in B-DNA, a more positive intense band appears at 280 nm. We used CD spectroscopy to monitor the conformational state at various NaCl concentrations (Figure 2). We observed that d(CGCFGCG)2 containing one FG greatly stabilized the Z-DNA, showing a Z-form CD spectrum even in the presence of 10 mM NaCl at a lower physiological salt concentration (Figure 2A), and the midpoint for the B–Z transition was 22 mM (Table 1), while the value for the natural sequence was 2600 mM (Figure 2B and Table 1), which suggested that trifluoromethyl DNA could reduce the demand for NaCl by >100-fold compared with the natural sequence. The effect of Z-DNA stabilization was also confirmed in the 8-mer DNA duplex d(CFGCACFGCG)/d(CGCGTGCG) with two FG and an AT base pair that does not favor the formation of Z-DNA. The midpoint of the duplex with two FG was the 148 mM NaCl concentration, which was lower than that of the natural 8-mer duplex (>5000 mM) (Figure 2C, D and Table 1). We further introduced the FG into the complementary sequence of the 8-mer DNA sequence d(CFGCACFGCG)/d(CFGCGTFGCG). The CD result suggested that even without addition of NaCl into the solution, the four positions modified DNA sequence can form a stable Z-DNA structure (Supplementary Figure S13). In Z-DNA, dG adopts a syn conformation; thus, the preferred syn conformation of FG induced by the CF3 group contributed to the stabilization of the Z-DNA. Therefore, the CD experiment results suggested the FG could dramatically stabilize the Z-DNA conformation at a physiological salt condition, which is quite important for further studying Z-DNA structure in living cells by 19F NMR spectroscopy. Other fluorinated nucleosides could be used as 19F NMR sensors (44), but they do not possess the ability to stabilize the Z-DNA conformation at physiological salt conditions. Therefore, this result highlights the superiority of FG for further 19F NMR study of Z-DNA structure in vitro and in living cells compared with other fluorinated nucleosides.
Table 1.
Oligonucleotides | NaCl (mM) |
---|---|
d(CGCGCG)2 | 2600 |
d(CGCFGCG)2 | 22 |
d(CGCACGCG)/d(CGCGTGCG) | >5000 |
d(CFGCACFGCG)/d(CGCGTGCG) | 148 |
d(CFGCACFGCG)/d(CFGCGTFGCG) | 0 |
2D NMR analysis of trifluoromethyl Z-DNA structure
We further performed the 2D NMR experiment to confirm the formation of Z-DNA structure of the trifluoromethyl modified DNA sequences in 100 mM NaCl. The non-exchangeable protons were assigned based on the 2D NOESY experiment in D2O (Figure 3). The H8/H1′ cross-peak region of the 2D NOESY spectrum showed only strong intranucleotide G2H8–G2H1′ and G6H8–G6H1′ cross-peaks, which indicated the syn conformation of dG residues (Figure 3A). Another evidence for the Z-DNA structure is the unusually upshift of the H5 proton of C3 and C5 to 5.03 and 5.11 ppm since the ring current influence of the dG bases on the 3′-side in Z-DNA (28). We further extended the assignment to the aromatic-H2′/H2″ (Figure 3B) and finally to all regions of the spectrum. Sequential assignments of C1 to C3 and G4 to G6 for the Z-DNA can be detected based on the aromatic-H2″ pathway (Figure 3B, red lines), indicating the sequence-specific connectivity for left-handed helices. Figure 3C showed clearly cross-peaks between H1′ and H2′/H2″. The chemical shifts of all 1H signals are displayed in Supplementary Table S1. Consistent with previous studies, the H2′ and H5′ proton of dC unusually upfield also, indicated the Z-DNA conformation (28).
The exchangeable proton NMR spectrum in 90% H2O of the modified sequence was shown in Figure 3D and Supplementary Figure S14. The cross-peaks of the exchangeable protons are also consistent with Z-DNA conformation. Similar to the previous study, the cross-peaks of C5H4 (amino) and C1H5 were observed (Figure 3D) (28). These cross-peaks could be only observed in the Z-DNA conformation. Moreover, the clear cross-peaks of the imino proton of dG (∼13.3 ppm) and the amino proton of dC suggested Watson–Crick base pairs (Supplementary Figure S14). All of the evidence suggested the FG modified 6-mer oligonucleotide could adopt Z-DNA structure under a physiological salt condition.
The structural model of d(CGCFGCG)2 is constructed based on the reported Z-form structure and NOE-constrained refining method (31). The molecular dynamics simulation was carried out in BIOVIA Discovery Studio 4.5 through a standard dynamic cascade with some modifications. The lowest energy conformation was selected as shown in Figure 4. The hydrophobic trifluoromethyl groups are located outside of the helix, which is consistent with the previous studies that the induction of a trifluoromethyl group into the C8 position of dG could strongly improve the stability of Z-form oligonucleotide.
19F NMR characterization of trifluoromethyl Z-DNA structure in vitro and in living Hela cells
Based on the concept that 19F NMR signals are strongly dependent on the structural environment of the 19F label, the 19F atom in trifluoromethyl DNA as a 19F sensor provides the 19F NMR signals that can be used as a powerful tool for the analysis of biomolecule conformation by 19F NMR spectroscopy. Thus, it is possible to distinguish B- and Z-DNA structures by the different chemical shifts in 19F NMR spectra (Figure 5A). In 6-mer duplex DNA d(CGCFGCG)2, only one signal was observed at −61.79 ppm in the absence of NaCl, indicating that the B-form DNA was consistent with the CD result. A new signal appears as the NaCl concentration increases (−61.29 ppm). The new signal is clearly observed at a NaCl concentration of 10 mM. The intensity of the new signal is markedly greater than that of the initial peak at 30 mM NaCl concentration (Figure 5B). To combine the CD and 2D NOESY results, we assigned the new peak as a Z-DNA structure. The 8-mer DNA duplex with two FG was then created to confirm the assignment using 19F NMR (Figure 5C). There are two 19F NMR signals could be observed in the absence of NaCl. Two 19F NMR peaks result from two asymmetric FG due to their different positions within the 8-mer duplex sequence. With increasing NaCl concentration, the two peaks significantly decreased and completely disappeared in B-DNA, and two new strong-intensity peaks appeared as Z-DNA. Thus, we could conclude that the trifluoromethylated oligonucleotide DNA allowed us to directly observe the DNA structural conversion from B- to Z-DNA. The 19F NMR experiment was also performed with the four positions modified 8-mer DNA (Supplementary Figure S13b). Four 19F NMR signals were observed between –61.3 and –61.5 ppm, which are assigned to the four modified dGs. There is no chemical shift change after addition of NaCl into this sample. This 19F NMR result is in good agreement with the CD spectra that the four positions modified sequence could form a stable Z-DNA structure even in the absence of NaCl and further addition of NaCl could not change the DNA conformation.
Encouraged by the ability to use 19F NMR spectroscopy to monitor the conformation of DNA, we utilized 19F NMR to observe Z-DNA in living human cells. In-cell NMR is a powerful tool to study the structure and relative biological event at the really intracellular environment (45,46). Direct observation of the Z-DNA structure in human cells will offer critical information to further understand its biological functions. An in-cell 19F NMR spectroscopy strategy is shown in Figure 6A, showing that comparing the in-cell 19F-NMR spectrum to the in vitro result as a reference enables a reliable determination of the intracellular Z-DNA conformation. The d(CGCFGCG)2 sequence was transfected into HeLa cells by using an SLO treatment approach (40). Figure 6B shows a comparison of the in vitro B-DNA, Z-DNA and in-cell NMR spectra. One signal was observed at the bottom of the in-cell NMR spectrum, for which the chemical shift was identical to that observed for the corresponding Z-DNA in the in vitro19F NMR spectrum (top). The in vivo NMR spectrum has a little broad line width compared to the sample in dilute solution due to the inherent sample inhomogeneity and high viscosity of the intracellular environment (47). After the NMR measurement, the suspension was collected and examined by 19F NMR spectroscopy. Almost no signal was observed from the supernatant (Figure 6B), indicating that almost all of the NMR signals originated from the 19F labeled DNA within the HeLa cells. We also generated a difference spectrum between the HeLa cells and the suspension to eliminate the signal from the supernatant. Thus, the in-cell 19F NMR data demonstrate that the trifluoromethyl DNA can be present in a Z-DNA conformation in living cells. To our best knowledge, this is the first time to directly observe the Z-DNA conformation in living cells by NMR spectroscopy.
We further performed the in-cell 19F NMR experiment of the modified 8-mer DNA sequence d(CFGCACFGCG)/d(CGCGTGCG), which requires a higher concentration of NaCl for B–Z transition. As shown in Supplementary Figure S15, the 8-mer DNA sequence could form both Z-DNA and B-DNA structure in Hela cells. This result could offer the opportunity for further investigating the B-Z DNA structural transition in living cells in the future.
We further tried to estimate the effective concentration of the trifluoromethyl DNA within cells. It is difficult to directly obtain the transfected DNA concentration in living cells. In a previous study, the authors used the same SLO approach to transfect protein into HeLa cells for in-cell NMR study (48). They demonstrated that 1 mM protein incubated with cells could result in 50 μM intracellular concentration of protein and further yield an estimate of 4 μM for the protein concentration of the NMR sample. In this study, we used the same approach to transfect the DNA into Hela cells and a 3 mM concentration of DNA was used to incubate with the cells. Therefore, we assumed that approximately 150 μM transfected DNA concentration could be obtained and the final concentration of the NMR sample is about 12 μM. To verify the speculate, we further performed the in vitro experiment of the trifluoromethyl 6-mer DNA sample at 12 μM strand concentration to compare with the in-cell spectrum (Figure 6B, bottom). We found that the intensity of the in vitro sample is comparable with the in-cell result. Therefore, we demonstrated that the transfect DNA concentration in living cells is about 150 μM.
Monitor DNA-protein interaction by 19F NMR spectroscopy
Finally, we utilized the trifluoromethyl oligonucleotide to study DNA–protein interactions. Zα domain, an NH2-terminus of ADAR1, is reported for binding to Z-form DNA with high-affinity and stabilizing the Z-DNA structure (49). When the Zα binds to the DNA, a different 19F NMR chemical shift is expected to be observed because the local environment around the trifluoromethyl group changed. Addition of the 1 equivalent Zα to a solution of FG labeled 6-mer DNA sample induced a new signal at –61.13 ppm in the 19F NMR spectra (Figure 7A). The new signal was assigned to the complex of DNA-Zα in accordance with the previous reports (11,43). We note that the original signal of free DNA still remains, which suggested 1 equivalent Zα is not enough to bind with the 6-mer DNA. When 2 equivalent Zα domain was added to the DNA sample, the original peak for the free DNA disappeared and only the complex of DNA-Zα signal appeared, which is in good agreement with previous studies that a Z-DNA sequence could bind with two Zα (11,43). We also performed the 19F NMR experiment to monitor the interaction of 8-mer DNA d(CFGCACFGCG)/d(CGCGTGCG) and Zα protein (Figure 7B). After addition of 1 equivalent Zα, two new peaks appeared and the original peaks for free DNA completely disappeared after the addition of 2 equivalent Zα protein. CD experiment was employed to verify the binding of Zα and FG labeled DNA sequences (Figure 7C and D). In the 1: 1 ratio of DNA and Zα, the peak intensity at 295 nm decreased and around 275 nm increased, which indicated the Zα binds with FG labeled 6-mer and 8-mer DNA and stabilizes the Z-DNA conformation, consistent with our previous report (43). Addition of 2 equivalent Zα could further change the intensity of the peaks. These results demonstrate that the trifluoromethyl DNA can be used to investigate the interaction of Z-DNA with protein. We further performed 19F NMR and CD experiments of the four positions modified DNA d(CFGCACFGCG)/d(CFGCGTFGCG) and Zα protein (Supplementary Figure S16). In the 19F NMR spectra, the four peaks for Z-DNA conformation disappeared after addition of Zα protein and a broad signal appeared, which indicated the binding of Z-DNA and Zα protein. In the CD spectra, the addition of Zα protein did not induce a big change compared with the two positions modified 8-mer DNA (Figure 7D), because the four positions modified 8-mer sequence can form Z-DNA structure even in the absence of NaCl or Zα protein. We also employed the CD experiment to monitor the interaction of native 8-mer DNA d(CGCACCG)/d(CGCGTGCG) and Zα protein (Supplementary Figure S17). The CD result indicated that Zα protein could induce the B–Z transition of the native 8-mer DNA, but transition is not particularly effective in comparison with the two positions modified 8-mer DNA (Figure 7D), since the intensity of the peak around 275 nm for the modified sequence is about two times stronger than the native 8-mer DNA. We also found that the Zα protein alone does not show the signals between 250 and 320 nm (Supplementary Figure S18).
In conclusion, we have succeeded in incorporating a CF3 group into the 8-position of 2′-deoxyguanosine and site-specific trifluoromethyl oligonucleotide DNA. The trifluoromethyl oligonucleotides markedly stabilized the Z-DNA even under physiological salt concentrations. Furthermore, the CF3 group can be used as a 19F NMR probe to study Z-DNA structure and DNA–protein binding reaction in vitro and investigate the Z-DNA structure in living cells by 19F NMR spectroscopy. The results demonstrated that trifluoromethyl oligonucleotide DNA provides a new approach for Z-DNA structure and function studies.
Supplementary Material
Contributor Information
Hong-Liang Bao, Division of Chemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Tatsuki Masuzawa, Faculty of Science, Department of Chemistry, Shizuoka University, 836 Ohya Suruga Shizuoka 422-8529, Japan.
Takanori Oyoshi, Faculty of Science, Department of Chemistry, Shizuoka University, 836 Ohya Suruga Shizuoka 422-8529, Japan.
Yan Xu, Division of Chemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Japan Society for the Promotion of Science KAKENHI [17H03091, 20K15402]; Naito Foundation; Ichiro Kanehara Foundation. Funding for open access charge: Japan Society for the Promotion of Science KAKENHI.
Conflict of interest statement. None declared.
REFERENCES
- 1. Rich A., Nordheim A., Wang A.H.. The chemistry and biology of left-handed Z-DNA. Annu. Rev. Biochem. 1984; 53:791–846. [DOI] [PubMed] [Google Scholar]
- 2. Blaho J.A., Wells R.D.. Left-handed Z-DNA binding by the recA protein of Escherichia coli. J. Biol. Chem. 1987; 262:6082–6088. [PubMed] [Google Scholar]
- 3. Kmiec E.B., Angelides K.J., Holloman W.K.. Left-handed DNA and the synaptic pairing reaction promoted by Ustilago rec1 protein. Cell. 1986; 40:139–145. [DOI] [PubMed] [Google Scholar]
- 4. Oh D.B., Kim Y.G., Rich A.. Z-DNA-binding proteins can act as potent effectors of gene expression in vivo. Proc. Natl. Acad. Sci. U.S.A. 2002; 99:16666–16671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Champ P.C., Maurice S., Vargason J.M., Camp T., Ho P.S.. Distributions of Z-DNA and nuclear factor I in human chromosome 22: a model for coupled transcriptional regulation. Nucleic Acids Res. 2004; 32:6501–6510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Liu R., Liu H., Chen X., Kirby M., Brown P.O., Zhao K.. Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell. 2001; 106:309–318. [DOI] [PubMed] [Google Scholar]
- 7. Koehler H., Cotsmire S., Langland J., Kibler K.V., Kalman D., Upton J.W., Mocarski E.S., Jacobs B.L.. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3. Proc. Natl. Acad. Sci. U.S.A. 2017; 114:11506–11511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Ha S.C., Lowenhaupt K., Rich A., Kim Y.G., Kim K.K.. Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases. Nature. 2005; 437:1183–1186. [DOI] [PubMed] [Google Scholar]
- 9. Kang Y.M., Bang J., Lee E.H., Ahn H.C., Seo Y.J., Kim K.K., Kim Y.G., Choi B.S., Lee J.H.. NMR spectroscopic elucidation of the B-Z transition of a DNA double helix induced by the Z alpha domain of human ADAR1. J. Am. Chem. Soc. 2009; 131:11485–11491. [DOI] [PubMed] [Google Scholar]
- 10. Zhang Y., Cui Y., An R., Liang X., Li Q., Wang H., Wang H., Fan Y., Dong P., Li J. et al.. Topologically constrained formation of stable Z-DNA from normal sequence under physiological conditions. J. Am. Chem. Soc. 2019; 141:7758–7764. [DOI] [PubMed] [Google Scholar]
- 11. Bae S., Kim D., Kim K.K., Kim Y.-G., Hohng S.. Intrinsic Z-DNA is stabilized by the conformational selection mechanism of Z-DNA-binding proteins. J. Am. Chem. Soc. 2011; 133:668–671. [DOI] [PubMed] [Google Scholar]
- 12. Lee A.R., Park C.J., Cheong H.K., Ryu K.S., Park J.W., Kwon M.Y., Lee J., Kim K.K., Choi B.S., Lee J.H.. Solution structure of the Z-DNA binding domain of PKR-like protein kinase from Carassius auratus and quantitative analyses of the intermediate complex during B-Z transition. Nucleic Acids Res. 2016; 44:2936–2948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Kim S.H., Lim S.H., Lee A.R., Kwon D.H., Song H.K., Lee J.H., Cho M., Johner A., Lee N.K., Hong S.C.. Unveiling the pathway to Z-DNA in the protein-induced B-Z transition. Nucleic Acids Res. 2018; 46:4129–4137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Brown B.A., Lowenhaupt K., Wilbert C.M., Hanlon E.B., Rich A.. The Zα domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA. Proc. Natl. Acad. Sci. U.S.A. 2000; 97:13532–13536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Subramani V.K., Kim D., Yun K., Kim K.K.. Structural and functional studies of a large winged Z-DNA-binding domain of Danio rerio protein kinase PKZ. FEBS Lett. 2016; 590:2275–2285. [DOI] [PubMed] [Google Scholar]
- 16. de Rosa M., Zacarias S., Athanasiadis A.. Structural basis for Z-DNA binding and stabilization by the zebrafish Z-DNA dependent protein kinase PKZ. Nucleic. Acids Res. 2013; 41:9924–9933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kim K., Khayrutdinov B.I., Lee C.K., Cheong H.K., Kang S.W., Park H., Lee S., Kim Y.G., Jee J., Rich A. et al.. Solution structure of the Zβ domain of human DNA-dependent activator of IFN-regulatory factors and its binding modes to B- and Z-DNAs. Proc. Natl. Acad. Sci. U.S.A. 2011; 108:6921–6926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Ha S.C., Kim D., Hwang H.Y., Rich A., Kim Y.G., Kim K.K.. The crystal structure of the second Z-DNA binding domain of human DAI (ZBP1) in complex with Z-DNA reveals an unusual binding mode to Z-DNA. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:20671–20676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Kim D., Hur J., Park K., Bae S., Shin D., Ha S.C., Hwang H.Y., Hohng S., Lee J.H., Lee S. et al.. Distinct Z-DNA binding mode of a PKR-like protein kinase containing a Z-DNA binding domain (PKZ). Nucleic Acids Res. 2014; 42:5937–5948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Lee A.R., Park C.J., Cheong H.K., Ryu K.S., Park J.W., Kwon M.Y., Lee J., Kim K.K., Choi B.S., Lee J.H.. Solution structure of the Z-DNA binding domain of PKR-like protein kinase from Carassius auratus and quantitative analyses of the intermediate complex during B-Z transition. Nucleic Acids Res. 2016; 44:2936–2948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Herbert A. Z-DNA and Z-RNA in human disease. Commun Biol. 2019; 2:7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Ravichandran S., Subramani V.K., Kim K.K.. Z-DNA in the genome: from structure to disease. Biophys. Rev. 2019; 11:383–387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Jiao H., Wachsmuth L., Kumari S., Schwarzer R., Lin J., Eren R.O., Fisher A., Lane R., Young G.R., Kassiotis G. et al.. Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature. 2020; 580:391–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Zhang T., Yin C., Boyd D.F., Quarato G., Ingram J.P., Shubina M., Ragan K.B., Ishizuka T., Crawford J.C., Tummers B. et al.. Influenza virus Z-RNAs induce ZBP1-Mediated necroptosis. Cell. 2020; 180:1115–1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Egli M., Williams L.D., Gao Q., Rich A.. Structure of the pure-spermine form of Z-DNA (magnesium free) at 1-A resolution. Biochemistry. 1991; 30:11388–11402. [DOI] [PubMed] [Google Scholar]
- 26. Harp J.M., Coates L., Sullivan B., Egli M.. Cryo-neutron crystallographic data collection and preliminary refinement of left-handed Z-DNA d(CGCGCG). Acta Crystallogr. F Struct. Biol. Commun. 2018; 74:603–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Bancroft D., Williams L.D., Rich A., Egli M.. The low-temperature crystal structure of the pure-spermine form of Z-DNA reveals binding of a spermine molecule in the minor groove. Biochemistry. 1994; 33:1073–1086. [DOI] [PubMed] [Google Scholar]
- 28. Sugiyama H., Kawai K., Matsunaga A., Fujimoto K., Saito I., Robinson H., Wang A.H.. Synthesis, structure and thermodynamic properties of 8-methylguanine-containing oligonucleotides: Z-DNA under physiological salt conditions. Nucleic Acids Res. 1996; 24:1272–1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Xu Y., Ikeda R., Sugiyama H.. 8-Methylguanosine: a powerful Z-DNA stabilizer. J. Am. Chem. Soc. 2003; 125:13519–13524. [DOI] [PubMed] [Google Scholar]
- 30. Balasubramaniyam T., Ishizuka T., Xu Y.. Stability and properties of Z-DNA containing artificial nucleobase 2′-O-methyl-8-methyl guanosine. Bioorg. Med. Chem. 2019; 27:364–369. [DOI] [PubMed] [Google Scholar]
- 31. Balasubramaniyam T., Ishizuka T., Xiao C.D., Bao H.L., Xu Y.. 2′-O-Methyl-8-methylguanosine as a Z-Form RNA stabilizer for structural and functional study of z-RNA. Molecules. 2019; 23:2572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Vongsutilers V., Gannett P.M.. C8-Guanine modifications: effect on Z-DNA formation and its role in cancer. Org. Biomol. Chem. 2018; 16:2198–2209. [DOI] [PubMed] [Google Scholar]
- 33. Bao H.L., Xu Y.. Telomeric DNA-RNA-hybrid G-quadruplex exists in environmental conditions of HeLa cells. Chem. Commun. (Camb.). 2020; 56:6547–6550. [DOI] [PubMed] [Google Scholar]
- 34. Bao H.L., Ishizuka T., Iwanami A., Oyoshi T., Xu Y.. A simple and sensitive 19F NMR approach for studying the interaction of RNA G-Quadruplex with ligand molecule and protein. ChemistrySelect. 2017; 2:4170–4175. [Google Scholar]
- 35. Chen H., Viel S., Ziarelli F., Peng L.. 19F NMR: a valuable tool for studying biological events. Chem. Soc. Rev. 2013; 42:7971–7982. [DOI] [PubMed] [Google Scholar]
- 36. Fauster K., Kreutz C., Micura R.. 2′-SCF3 uridine-a powerful label for probing structure and function of RNA by 19F NMR spectroscopy. Angew. Chem. Int. Ed. 2012; 51:13080–13084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Granqvist L., Virta P.. Characterization of G-quadruplex/hairpin transitions of RNAs by 19F NMR spectroscopy. Chem. Eur. J. 2016; 22:15360–15372. [DOI] [PubMed] [Google Scholar]
- 38. Bao H.L., Xu Y.. Investigation of higher-order RNA G-quadruplex structures in vitro and in living cells by 19F NMR spectroscopy. Nat. Protoc. 2018; 13:652–665. [DOI] [PubMed] [Google Scholar]
- 39. Bao H.L., Ishizuka T., Sakamoto T., Fujimoto K., Uechi T., Kenmochi N., Xu Y.. Characterization of human telomere RNA G-quadruplex structures in vitro and in living cells using 19F NMR spectroscopy. Nucleic Acids Res. 2017; 45:5501–5511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Bao H.L., Liu H.S., Xu Y.. Hybrid-type and two-tetrad antiparallel telomere DNA G-quadruplex structures in living human cells. Nucleic Acids Res. 2019; 47:4940–4947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Ishizuka T., Bao H.L., Xu Y.. 19F NMR spectroscopy for the analysis of DNA G-Quadruplex structures using 19F-Labeled nucleobase. Methods Mol. Biol. 2019; 2035:407–433. [DOI] [PubMed] [Google Scholar]
- 42. Ishizuka T., Zhao P.Y., Bao H.L., Xu Y.. A multi-functional guanine derivative for studying the DNA G-quadruplex structure. Analyst. 2017; 142:4083–4088. [DOI] [PubMed] [Google Scholar]
- 43. Oyoshi T., Kawai K., Sugiyama H.. Efficient C2′ alpha-hydroxylation of deoxyribose in protein-induced Z-form DNA. J. Am. Chem. Soc. 2003; 125:1526–1531. [DOI] [PubMed] [Google Scholar]
- 44. Guo F., Li Q., Zhou C.. Synthesis and biological applications of fluoro-modified nucleic acids. Org. Biomol. Chem. 2017; 15:9552–9565. [DOI] [PubMed] [Google Scholar]
- 45. Hansel R., Luh L.M., Corbeski I., Trantirek L., Dotsch V.. In-Cell NMR and EPR spectroscopy of biomacromolecules. Angew. Chem. Int. Ed. 2014; 53:10300–10314. [DOI] [PubMed] [Google Scholar]
- 46. Dzatko S., Krafcikova M., Hansel-Hertsch R., Fessl T., Fiala R., Loja T., Krafcik D., Mergny J.L., Foldynova-Trantirkova S., Trantirek L.. Evaluation of the stability of DNA i-Motifs in the nuclei of living mammalian cells. Angew. Chem. Int. Ed. 2018; 57:2165–2169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hansel R., Foldynova-Trantirkova S., Lohr F., Buck J., Bongartz E., Bamberg E., Schwalbe H., Dotsch V., Trantirek L.. Evaluation of parameters critical for observing nucleic acids inside living Xenopus laevis oocytes by In-Cell NMR spectroscopy. J. Am. Chem. Soc. 2009; 131:15761–15768. [DOI] [PubMed] [Google Scholar]
- 48. Ogino S., Kubo S., Umemoto R., Huang S., Nishida N., Shimada I.. Observation of NMR signals from proteins introduced into living mammalian cells by reversible membrane permeabilization using a pore-forming toxin, Streptolysin O. J. Am. Chem. Soc. 2009; 131:10834–10835. [DOI] [PubMed] [Google Scholar]
- 49. Schwartz T., Rould M.A., Lowenhaupt K., Herbert A., Rich A.. Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science. 1999; 84:1841–1845. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.